Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CH17-270A2.2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | SYNPO | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | SIDT1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | NLRP7 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | SLC27A4 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | TUBG1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | KRTAP17-1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | SCGB1D1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | SPACA7 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | RP11-435I10.4 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |